Le Lézard
Classified in: Health
Subject: PDT

Provista Launches One-Stop Web Destination For Industry News, Features And Information

IRVING, Texas, Oct. 6, 2017 /PRNewswire/ -- Provista, a proven leader in the supply chain industry with more than $100 billion in purchasing power, today announced a new resource area on Provistaco.com featuring industry news and information. The Newsroom is the online home for case studies, articles on supply chain and industry trends, infographics, expert bios, news releases, slideshows and events.

Provista logo

Besides having access to a wealth of resources at their fingertips, viewers can also watch short videos featuring Provista customers and experts, and interact with the site to learn more about the features, benefits, products and services an innovative supply chain partner can offer. Additional content, including exclusive surveys, will be continually added to bring visitors the very latest industry news and trends.

"We're excited to launch an information-rich, user-friendly resource center that helps customers, suppliers and distributors better understand the critical role and exclusive value that a supply chain partner brings to non-acute healthcare facilities and other businesses," says Jim Cunniff, Provista President and CEO. "Supply chains are becoming increasingly complex, so  it's critical to provide real-time information to our customers on ways to improve purchasing and where they can gain additional value. We are now providing that information to help everyone involved in the supply chain stay informed."

The Newsroom is a digital outlet for Provista to share the knowledge and industry insights it has gained over the past 20 years as the supply chain authority for facilities such as surgery centers, physicians' offices, urgent care clinics and the like. Customers as well as anyone within the industry can find valuable, actionable information designed to help them make smarter purchasing decisions for their facility or business.

"Our site is a one-stop destination for anyone who wants to 'be in the know' regarding our industry and the unique value Provista brings to the markets we serve. Our customer testimonials are particularly impactful in understanding the role we play in delivering exceptional value to our customers," Cunniff says. "Learning about our industry, finding out why Provista is unique in the marketplace and hearing our customers' stories is only a click away."

About Provista

Founded in 1994, Provista is a proven supply chain partner. Provista offers customers extensive product coverage with more than $100 billion in purchasing power across a multitude of segments, including surgical care, physician offices, urgent care clinics, home infusion and closed door pharmacy. The company also delivers value beyond contracts, providing customized purchasing solutions. For more information, visit provistaco.com/newsroom.


SOURCE Provista

These press releases may also interest you

at 07:30
MabVax Therapeutics Holdings, Inc. , a clinical-stage biotechnology company focused on the development of antibody-based products to address unmet medical needs in the treatment of cancer, announced today the completion of enrollment and dosing of...

at 07:30
Pionyr Immunotherapeutics, Inc., a company developing antibody therapeutics that increase the body's antitumor immunity by rebalancing the myeloid infiltrate in the tumor microenvironment, announced the closing of a $62 million Series B investment...

at 07:30
BIOREM Inc. ("Biorem" or "the Company") today announced several new orders totalling $7.0 million.  The orders are for air emission abatement projects in China and North America. "Our focus for business development in 2017 has been primarily...

at 07:30
According to Transparency Market Research, the global physiotherapy devices market was valued at US$1,686.1 mn in 2016 and is expected to reach US$2,838.9 mn by the end of 2025. During the forecast period of 2017 and 2025, the global market is...

at 07:15
The "Growth Insights on the Global CRISPR/Cas9 Tools Market, 2017" report has been added to Research and Markets' offering. Since its inception, CRISPR has gained strong traction from the global research community because of its huge potential in...

at 07:10
In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on CVRS, NSPR, EYES, and RSLS which is a click away at www.wallstequities.com/registration....

News published on 6 october 2017 at 09:30 and distributed by: